Comprehensive screening for the conditions that matter most

Our Textile Computing® platform enables continuous, multi-parameter monitoring to detect and manage a wide range of health conditions. From cardiac arrhythmias to sleep disorders, we provide the data you and your healthcare team need for proactive care.

Current and future screening capabilities

From a single garment, a holistic view of well-being

The human body is an interconnected system. Our Textile Computing® platform is uniquely designed to capture multiple biometrics concurrently, enabling Holistic Screening™ that creates a far more powerful and complete picture of patient health.

  • Stroke
  • Heart failure / heart attack
  • Heart rhythm disorders (atrial fibrillation)
  • Obstructive sleep apnea
  • Respiratory care
  • Hypertension
  • Diabetes mellitus
  • Musculoskeletal health

Stroke

795,000 (US) • 108,000 (Canada) • 9.5M (EU) • 7.3M (MENA)[1]

Early detection through continuous cardiovascular monitoring and irregular heart rhythm identification. Stroke prevention relies on detecting precursor conditions like atrial fibrillation and hypertension.

  • Heart rate variability (HRV)
  • Atrial fibrillation detection
  • Blood pressure trends
  • Cerebrovascular indicators

View clinical references

  1. CDC. Stroke Facts. National Center for Chronic Disease Prevention and Health Promotion, 2024. WHO Global Stroke Statistics, 2023.
  2. Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal, 2021;42(5):373-498.
  3. Tsao CW, et al. Heart Disease and Stroke Statistics—2023 Update. Circulation. 2023;147:e93-e621. WHO Cardiovascular Disease Report, 2023.
  4. Chaudhry SI, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363(24):2301-2309.
  5. Kornej J, et al. Epidemiology of Atrial Fibrillation in the 21st Century. Circ Res. 2020;127(1):4-20. ESC AFib Statistics, 2023.
  6. Steinhubl SR, et al. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation. JAMA. 2018;320(2):146-155.
  7. Benjafield AV, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med. 2019;7(8):687-698.
  8. Health Canada. Medical Device License #110765. Myant SKIIN™ Sleep Apnea Screening System, 2023.

All prevalence data represents diagnosed cases. Actual disease burden may be higher due to undiagnosed cases. Data sources accessed and verified as of 2024.